After breaking to higher ground back in June on large volume, shares of LA JOLLA PHARMACEUTICAL CO - NASDAQ:LJPC have been drifting in a sideways pattern consolidating the move in a constructive manner as we can observe from the Daily chart above.
With the stock trading above all of its important moving averages 20/50/200 DMA's, LJPC remains in decent technical...
COWAN AND CO RECENTLY ISSUED A BUY RATING AND A $25 PRICE TARGET ON NASDAQ:LJPC RESULTING IN A SPIKE IN PRICE AND VOLUME , WE EXPECT CONTINUATION IN THE DAYS AND WEEKS TO COME FOR SOME GREAT GAINS.
AVERAGE ANALYSTS PRICE TARGET $19.50
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
La Jolla Pharmaceutical Co. operates as a biopharmaceutical...
Biotech Stock with positive phase 2 results. HOT setup
"La Jolla Pharmaceutical Co. (LJPC) on Thursday reported positive results from the interim analysis of its phase 2 study of LJPC-401 (synthetic human hepcidin) in patients with hereditary...
LJPC: La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis - GlobeNewswire
LJPC had a huge jump & now seems forming a flag formation. The flag break did not occur yet, however in hourly frame we can see that it got nice base of support in the moving averages and seems getting ready for breakout. So we would like to take a speculative entry around $34 & our target would just below $42
* Trade Criteria *
Date First Found- February 28,...